The coronavirus pandemic has created havoc across the globe, with the number of infected cases and death tolls rising at an alarming rate. Governments are channelizing efforts to develop maximum test kits to control the pandemic in the shortest possible time. The medical devices and diagnostics companies are constantly analyzing the degree to which the coronavirus crisis will affect the business. Rising demand for diagnostics is subsequently bolstering the demand for viral molecular diagnostics. Moreover, the growing demand for testing kits from various end-users such as hospitals, laboratories, and academic institutions provide an impetus to the market growth. Increasing the use of advanced technologies, rising research activities, and increasing government funding to manufacture COVID-19 drugs and vaccines drive market growth.
In April 2020, Affinity Health Partners launched a COVID-19 point-of-care test, which is in compliance with the FDA-designed Coronavirus Policy (COVID-19) Virus Testing. Similarly, Randoxhas developed a rapid test for COVID-19 (SARS-CoV-2) using Randox Biochip Technology, reporting 540 results in less than 5 hours.
Got questions about your regional growth of
COVID-19 Testing Kits Market?
Just drop us a line or call on +1 646 480 7505
COVID-19 Testing Kits Market Segmentation
By Specimen Type
By End User
" Crucial Insights The Report Provides:"
* Known and Unknown Adjacencies Influencing the Growth of Market
* Explorable Revenue Sources
* Customer Behaviour Analysis
* Target Partners
* Customized Geographical Data Based on Customers as well as Competitors
* Analysis of Market Size and CAGR between the Forecast PeriodsView Full Report Buy This Report Now